During the past decade, Univerzitetni klinični center Maribor; Oddelek za onkologijo conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Univerzitetni klinični center Maribor; Oddelek za onkologijo" #1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Univerzitetni klinični center Maribor; Oddelek za onkologijo" are "Advanced Breast Cancer" (1 trials), "Breast Cancer" (1 trials), "Hepatocellular Carcinoma" (1 trials), "Hormone Receptor Positive Tumor" (1 trials) and "Human Epidermal Growth Factor 2 Negative Carcinoma of Breast" (1 trials). Many other conditions were trialed in "Univerzitetni klinični center Maribor; Oddelek za onkologijo" in a lesser frequency.

Most popular intervention types in "Univerzitetni klinični center Maribor; Oddelek za onkologijo" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Endocrine therapy" (1 trials), "Nab-Paclitaxel" (1 trials) and "Palbociclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Univerzitetni klinični center Maribor; Oddelek za onkologijo" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Univerzitetni klinični center Maribor; Oddelek za onkologijo". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Univerzitetni klinični center Maribor; Oddelek za onkologijo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Univerzitetni klinični center Maribor; Oddelek za onkologijo, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".